Cannasouth Investor Relations Material
Latest events
Investor Day 2023
Cannasouth
H2 2023
29 Feb, 2024
Trading Update
23 Jan, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Cannasouth Limited
Access all reports
Cannasouth Limited is a biopharmaceutical company focused on the research, development, and commercialization of medicinal cannabis products. The company operates in areas such as cannabinoid extraction, formulation, and clinical research to create therapeutic products for various health conditions. Cannasouth also engages in cultivation and processing through joint ventures, aiming to ensure high-quality, sustainably produced raw materials for its products. The company is headquartered in Hamilton, New Zealand, and its shares are listed on the NZX.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
CBD
Country
🇳🇿 New Zealand